HIKALNSEHikal Limited· PharmaceuticalsLowNeutral
Announced Wed, 20 May · 16:57 IST

Hikal Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

HIKAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.0%1-day move
₹203.60
prior close
₹205.98
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4+0.1-0.5+1.4+1.0+5.6+8.1+8.5-4.7-5.7-9.2+7.5+10.4
Up moveDown movePending
AI summary

Hikal Limited has scheduled an earnings conference call for Q4 & FY26 (ended March 31, 2026) on Wednesday, May 27, 2026, at 4:30 PM IST. The call will be hosted by Vice Chairman and Managing Director Mr. Sameer Hiremath along with CFO Mr. Kuldeep Jain and other senior leadership including Presidents of the Pharmaceuticals and Animal Health businesses. The dial-in details and universal access numbers have been shared for investor participation.

Likely market impact

This routine earnings call announcement signals that Q4 & FY26 results are expected to be announced shortly, allowing investors to prepare questions on the company's financial and operational performance. No material new information is disclosed in this filing.